JP2016507526A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016507526A5 JP2016507526A5 JP2015556185A JP2015556185A JP2016507526A5 JP 2016507526 A5 JP2016507526 A5 JP 2016507526A5 JP 2015556185 A JP2015556185 A JP 2015556185A JP 2015556185 A JP2015556185 A JP 2015556185A JP 2016507526 A5 JP2016507526 A5 JP 2016507526A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- sulfasalazine
- composition according
- polymer
- pvp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 claims 11
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 claims 11
- 229960001940 sulfasalazine Drugs 0.000 claims 11
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 claims 11
- 208000015122 neurodegenerative disease Diseases 0.000 claims 8
- 229920000642 polymer Polymers 0.000 claims 7
- 238000000034 method Methods 0.000 claims 6
- 229920003083 Kollidon® VA64 Polymers 0.000 claims 4
- 206010053395 Progressive multiple sclerosis Diseases 0.000 claims 4
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 4
- 238000000338 in vitro Methods 0.000 claims 4
- 230000004770 neurodegeneration Effects 0.000 claims 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000010922 spray-dried dispersion Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361759933P | 2013-02-01 | 2013-02-01 | |
| US61/759,933 | 2013-02-01 | ||
| US201361780340P | 2013-03-13 | 2013-03-13 | |
| US61/780,340 | 2013-03-13 | ||
| PCT/US2014/014290 WO2014121137A2 (en) | 2013-02-01 | 2014-01-31 | Compositions and methods for the treatment of neurodegenerative and other diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018079284A Division JP2018123159A (ja) | 2013-02-01 | 2018-04-17 | 神経変性およびその他の疾患の治療用組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016507526A JP2016507526A (ja) | 2016-03-10 |
| JP2016507526A5 true JP2016507526A5 (enExample) | 2017-02-23 |
| JP6328146B2 JP6328146B2 (ja) | 2018-05-23 |
Family
ID=50382538
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015556185A Expired - Fee Related JP6328146B2 (ja) | 2013-02-01 | 2014-01-31 | 神経変性およびその他の疾患の治療用組成物および方法 |
| JP2018079284A Pending JP2018123159A (ja) | 2013-02-01 | 2018-04-17 | 神経変性およびその他の疾患の治療用組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018079284A Pending JP2018123159A (ja) | 2013-02-01 | 2018-04-17 | 神経変性およびその他の疾患の治療用組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US9597339B2 (enExample) |
| EP (1) | EP2950797B1 (enExample) |
| JP (2) | JP6328146B2 (enExample) |
| KR (1) | KR20150139830A (enExample) |
| CN (1) | CN105163735B (enExample) |
| AU (2) | AU2014212109B2 (enExample) |
| CA (1) | CA2899032A1 (enExample) |
| ES (1) | ES2752021T3 (enExample) |
| IL (1) | IL240206A0 (enExample) |
| WO (1) | WO2014121137A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9597339B2 (en) * | 2013-02-01 | 2017-03-21 | Glialogix, Inc. | Compositions and methods for the treatment of neurodegenerative and other diseases |
| KR102364840B1 (ko) * | 2014-11-05 | 2022-02-18 | 삼성전자주식회사 | 신경세포의 탈수초화와 연관된 질환을 치료하기 위한 약학적 조성물 및 그를 이용하는 방법 |
| US20160199393A1 (en) * | 2015-01-08 | 2016-07-14 | China Medical University | Methods of treating brain ischemia or hypoxia |
| ES2650175B1 (es) * | 2016-04-15 | 2019-02-04 | Servicio Andaluz De Salud | Tratamiento de enfermedades neurodegenerativas |
| CN109414507A (zh) * | 2016-04-26 | 2019-03-01 | 美国圣路易斯大学 | 用于预防和治疗神经退行性疾病的高度选择性腺苷a3受体亚型激动剂 |
| US20180110760A1 (en) * | 2016-10-21 | 2018-04-26 | Glialogix, Inc. | Compositions and methods for the treatmentof neurodegenerative and other diseases |
| US10473672B2 (en) * | 2017-02-09 | 2019-11-12 | Kaohsiung Chang Gung Memorial Hospital | Methods for diagnosing and treating Alzheimers disease using G72 protein and SLC7A11 mRNA as biomarkers |
| US20230210871A1 (en) * | 2017-10-12 | 2023-07-06 | The Limited Company Research And Development Company "Medbiopharm" | Use of sulfasalazine as an inhibitor of the formation of advanced glycation end products |
| JP6603815B2 (ja) * | 2017-11-21 | 2019-11-06 | 積水化学工業株式会社 | 皮膚外用剤 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2396145A (en) | 1940-12-14 | 1946-03-05 | Pharmscia Ab | Heterocyclic sulphonamido azo compounds |
| FR2608988B1 (fr) | 1986-12-31 | 1991-01-11 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules |
| HUT77373A (hu) | 1994-09-29 | 1998-03-30 | Andaris Limited | Porlasztva szárított mikrorészecskék gyógyszerészeti hordozóként |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| ITMI962356A1 (it) | 1996-11-13 | 1998-05-13 | Uni Degli Studi Di Brescia D I | Uso di composti derivati da molecole ad attivita' antinfiammatoria di tipo non steroideo per la prevenzione e il trattamento di |
| WO1998031346A1 (en) | 1997-01-16 | 1998-07-23 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| CA2336139C (en) | 1998-06-24 | 2008-10-14 | Advanced Inhalation Research, Inc. | Large porous particles emitted from an inhaler |
| EP1107743B1 (en) | 1998-08-25 | 2007-06-27 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
| US6586008B1 (en) | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
| KR100417623B1 (ko) | 2000-03-28 | 2004-02-05 | 주식회사 뉴로테크 | 뇌질환 예방 및 치료용 조성물 |
| CA2307278A1 (en) | 2000-04-28 | 2001-10-28 | University Of British Columbia | Use of n-heterocyclic substituted salicylic acids for inhibition of cellular uptake of cystine |
| WO2003063822A2 (en) | 2002-02-01 | 2003-08-07 | Pfizer Products Inc. | Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| EP1469830A2 (en) | 2002-02-01 | 2004-10-27 | Pfizer Products Inc. | Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles |
| CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
| US20060045865A1 (en) | 2004-08-27 | 2006-03-02 | Spherics, Inc. | Controlled regional oral delivery |
| US8748445B2 (en) | 2004-10-27 | 2014-06-10 | The Uab Research Foundation | Methods for treating glioma |
| US8034765B2 (en) | 2005-08-31 | 2011-10-11 | Abraxis Bioscience, Llc | Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| US20070053869A1 (en) | 2005-09-02 | 2007-03-08 | Yuichi Sugiyama | Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| GB0602123D0 (en) * | 2006-02-02 | 2006-03-15 | Novartis Ag | Organic compounds |
| CA2637255C (en) | 2006-02-02 | 2018-06-12 | Novartis Ag | 40-o-(2-hydroxyethyl)-rapamycin for treating tuberous sclerosis disorders |
| US7964585B2 (en) | 2006-03-14 | 2011-06-21 | Case Western Reserve University | Composition and method of treating peripheral neuropathy |
| KR101468053B1 (ko) | 2006-08-31 | 2014-12-02 | 앱탈리스 파마테크, 인코포레이티드 | 약 염기성 약물의 고용체를 포함하는 약물 전달 시스템 |
| WO2008135828A2 (en) | 2007-05-03 | 2008-11-13 | Pfizer Products Inc. | Nanoparticles comprising a drug, ethylcellulose, and a bile salt |
| WO2009073215A1 (en) | 2007-12-06 | 2009-06-11 | Bend Research, Inc. | Pharmaceutical compositions comprising nanoparticles and a resuspending material |
| EP2259777A2 (en) * | 2008-02-28 | 2010-12-15 | BIAL - Portela & Ca., S.A. | Pharmaceutical composition for poorly soluble drugs |
| SI2113254T1 (sl) * | 2008-04-28 | 2013-01-31 | Txcell | Sestave za zdravljenje vnetnih avtoimunskih stanj |
| TW201438738A (zh) | 2008-09-16 | 2014-10-16 | Genentech Inc | 治療進展型多發性硬化症之方法 |
| EP2411137B1 (en) | 2009-03-27 | 2016-09-07 | Bend Research, Inc. | Spray-drying process |
| US9084976B2 (en) | 2010-09-03 | 2015-07-21 | Bend Research, Inc. | Spray-drying apparatus and methods of using the same |
| EP2611530B1 (en) | 2010-09-03 | 2019-01-16 | Bend Research, Inc. | Spray-drying apparatus and methods of using the same |
| WO2013115965A1 (en) | 2012-01-31 | 2013-08-08 | Cerulean Pharma Inc. | Polymer-agent conjugates, particles, compositions, and related methods of use |
| US9597339B2 (en) * | 2013-02-01 | 2017-03-21 | Glialogix, Inc. | Compositions and methods for the treatment of neurodegenerative and other diseases |
| CA2935307C (en) | 2013-12-31 | 2023-05-09 | Ascendia Pharmaceuticals, Llc | Pharmaceutical compositions for poorly water-soluble compounds |
-
2014
- 2014-01-31 US US14/170,405 patent/US9597339B2/en not_active Expired - Fee Related
- 2014-01-31 JP JP2015556185A patent/JP6328146B2/ja not_active Expired - Fee Related
- 2014-01-31 EP EP14712798.9A patent/EP2950797B1/en active Active
- 2014-01-31 CA CA2899032A patent/CA2899032A1/en not_active Abandoned
- 2014-01-31 WO PCT/US2014/014290 patent/WO2014121137A2/en not_active Ceased
- 2014-01-31 KR KR1020157023718A patent/KR20150139830A/ko not_active Withdrawn
- 2014-01-31 CN CN201480019892.8A patent/CN105163735B/zh not_active Expired - Fee Related
- 2014-01-31 AU AU2014212109A patent/AU2014212109B2/en not_active Ceased
- 2014-01-31 ES ES14712798T patent/ES2752021T3/es active Active
-
2015
- 2015-07-29 IL IL240206A patent/IL240206A0/en unknown
-
2016
- 2016-11-30 US US15/365,835 patent/US9974798B2/en not_active Expired - Fee Related
- 2016-11-30 US US15/365,843 patent/US9980978B2/en not_active Expired - Fee Related
-
2017
- 2017-02-10 US US15/430,294 patent/US9918997B2/en not_active Expired - Fee Related
-
2018
- 2018-04-17 US US15/955,020 patent/US10398713B2/en not_active Expired - Fee Related
- 2018-04-17 JP JP2018079284A patent/JP2018123159A/ja active Pending
- 2018-08-28 AU AU2018222921A patent/AU2018222921A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016507526A5 (enExample) | ||
| WO2015120110A3 (en) | Novel pharmaceutical formulations | |
| MX370853B (es) | Formulaciones que contienen dapagliflozina amorfa. | |
| WO2015042078A8 (en) | Substituted aminopyrimidine compounds and methods of use | |
| WO2017132432A8 (en) | Benzimidazole derivatives as modulators of ror-gamma | |
| SG190448A1 (en) | Rapidly dispersing granules, orally disintegrating tablets and methods | |
| WO2015018380A3 (en) | Therapeutic nanoparticles and the preparation methods thereof | |
| NZ728392A (en) | High dosage strength tablets of rucaparib | |
| WO2011099832A3 (en) | Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same | |
| WO2014179564A8 (en) | Thiazolopyrrolidine inhibitors of ror-gamma | |
| WO2013158814A8 (en) | Immediate release, abuse deterrent pharmaceutical compositions | |
| WO2013134047A3 (en) | Aminoquinoline derivatives and uses thereof | |
| NZ721952A (en) | Delayed release compositions of linaclotide | |
| TN2017000497A1 (en) | Orodispersible dosage unit containing an estetrol component | |
| IN2013MU03583A (enExample) | ||
| HK1203815A1 (en) | Pharmaceutical compositions and methods for their preparation | |
| HK1217092A1 (zh) | 治疗性化合物及其用途 | |
| HK1215191A1 (zh) | 低剂量医药组合物 | |
| WO2014081581A3 (en) | Highly loaded amorphous efavirenz composition and process for preparing the same | |
| WO2015173701A3 (en) | Pharmaceutical compositions comprising danirixin for treating infectious diseases | |
| MD4563B1 (ro) | Produs de comicronizare cu conţinut de acetat de ulipristal | |
| WO2012126441A3 (es) | Péptidos cíclicos con actividad antineoplásica y antiangiogénica. | |
| NZ727834A (en) | Fast acting orally disintegrating film | |
| MX2016005764A (es) | Formulacion en suspension acuosa que comprende nanoparticulas de antibioticos macrolidos. | |
| WO2016040814A3 (en) | Disulfide polymers and methods of use |